Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 23, Issue 2, Pages 304-316
Publisher
Elsevier BV
Online
2022-01-18
DOI
10.1016/s1470-2045(21)00705-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
- (2021) Edward Schaeffer et al. Journal of the National Comprehensive Cancer Network
- Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
- (2021) Laila A Gharzai et al. LANCET ONCOLOGY
- Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
- (2020) David Joseph et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ultrahypofractionated vs hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: a systematic review and meta-analysis of phase III randomized trials
- (2020) Eric J. Lehrer et al. RADIOTHERAPY AND ONCOLOGY
- Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic
- (2020) Edward Christopher Dee et al. JAMA Oncology
- Role of Androgen-Deprivation Therapy Remains Uncertain for Intermediate-Risk Patients When Using Dose-Escalated Radiotherapy
- (2020) Marisa A. Kollmeier et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
- (2020) Abdenour Nabid et al. EUROPEAN JOURNAL OF CANCER
- Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
- (2020) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
- (2019) Anders Widmark et al. LANCET
- A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer
- (2018) Daphna Y. Spiegel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
- (2018) James W Denham et al. LANCET ONCOLOGY
- Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202
- (2017) Colleen A.F. Lawton et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
- (2017) Charles N. Catton et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
- (2017) Wanling Xie et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
- (2017) Benjamin Lacas et al. LANCET ONCOLOGY
- PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer
- (2016) Andrew J. McPartlin et al. CANCER
- Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer
- (2016) Aaron D. Falchook et al. CANCER
- Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991
- (2016) Michel Bolla et al. JOURNAL OF CLINICAL ONCOLOGY
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
- (2016) David Dearnaley et al. LANCET ONCOLOGY
- Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades
- (2015) Nicola Fossati et al. BJU INTERNATIONAL
- Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
- (2015) Paul L. Nguyen et al. EUROPEAN UROLOGY
- Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
- (2015) Anthony V. D’Amico et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910
- (2015) Thomas M. Pisansky et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
- (2015) Almudena Zapatero et al. LANCET ONCOLOGY
- Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance
- (2014) Adam B. Weiner et al. EUROPEAN UROLOGY
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study
- (2013) Agnes Dechartres et al. ANNALS OF INTERNAL MEDICINE
- A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy
- (2013) Zachary S. Zumsteg et al. EUROPEAN UROLOGY
- A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions
- (2013) Aurelien Latouche et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Use and Interpretation of Competing Risks Regression Models
- (2012) J. J. Dignam et al. CLINICAL CANCER RESEARCH
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
- (2011) James W Denham et al. LANCET ONCOLOGY
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
- (2011) Christopher U. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial (Irish Clinical Oncology Research Group 97-01) Comparing Short Versus Protracted Neoadjuvant Hormonal Therapy Before Radiotherapy for Localized Prostate Cancer
- (2010) John G. Armstrong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
- (2010) Michel Bolla et al. LANCET ONCOLOGY
- Duration of Androgen Suppression in the Treatment of Prostate Cancer
- (2009) Michel Bolla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer
- (2008) Juanita Crook et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
- (2008) Mack Roach et al. JOURNAL OF CLINICAL ONCOLOGY
- What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?
- (2008) Marisa A Kollmeier et al. Nature clinical practice. Urology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More